Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: A meta-analysis

Journal of Invasive Cardiology

Volumn 22, Issue 7, 2010, Pages 312-316

  Juwana, Yahya B ^a,b   Rasoul, Saman ^a,b   Ottervanger, Jan Paul ^a,b   Suryapranata, Harry ^a,b  

^a ISALA HOSPITAL   (Netherlands)

^b Rumah Sakit Puri Cinere   (Indonesia)

Author keywords

angioplasty; drug eluting stents; reintervention; stent restenosis

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ACUTE CORONARY SYNDROME; ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MEDLINE; META ANALYSIS; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; STABLE ANGINA PECTORIS; STENT THROMBOSIS; SYSTEMATIC REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, BALLOON, CORONARY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; HUMANS; MYOCARDIAL INFARCTION; PACLITAXEL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SIROLIMUS; TREATMENT OUTCOME;

EID: 77957047551     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Schömig A, Dibra A, Windecker S, et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 2007;50:1373-1380.
2. Goy JJ, Stauffer JC, Siegenthaler M, et al. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: The TAXI trial. J Am Coll Cardiol 2005;45:308-311.
3. Kastrati A, Mehilli J, von Beckerath N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary instent restenosis: A randomized controlled trial. JAMA 2005;293:165-171.
4. Dibra A, Kastrati A, Mehilli J, et al. Paclitaxel-eluting or sirolimus eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-670.
5. de Lezo J, Medina A, Pan M, et al. Drug-eluting stents for complex lesions: Randomized rapamycin versus paclitaxel CORPAL study (Abstr). J Am Coll Cardiol 2005;45:75A.
6. Di Lorenzo E, Varricchio A, Lanzillo T, et al. Paclitaxel and sirolimus stent implantation in patients with acute myocardial infarction (Abstr). Circulation 2005;112:U538.
7. Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 2005;353:653-662.
8. Kaiser C, Brunner-La Rocca HP, Buser PT, et al. Incremental cost-effectiveness of drugeluting stents compared with a third generation bare-metal stent in a real-world setting: Randomised Basel Stent Kosten Effektivitats Trial (BASKET). Lancet 2005;366:921-929.
9. Cervinka P, Costa MA, Angiolillo DJ, et al. Head-to-head comparison between sirolimuseluting and paclitaxel-eluting stents in patients with complex coronary artery disease: An intravascular ultrasound study. Catheter Cardiovasc Interv 2006;67:846-851.
10. Han YL, Wang XZ, Jing QM, et al. Comparison of rapamycin and paclitaxel eluting stent in patients with multi-vessel coronary disease (in Chinese). Zhonghua Xin Xue Guan Bing Za Zhi 2006;34:123-126.
11. Mehilli J, Dibra A, Kastrati A, et al. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 2006;27:260-266.
12. Kim YH, Park SW, Lee SW, et al. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation 2006;114:2148-2153.
13. Morice MC, Colombo A, Meier B, et al. Sirolimusvs paclitaxel eluting stents in de novo coronary artery lesions: The REALITY trial: A randomized controlled trial. JAMA 2006;295:895-904.
14. Zhang Q, Zhang RY, Zhang JS, et al. One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease. Chin Med J (Engl) 2006;119:165-168.
15. Petronio AS, De Carlo M, Branchitta G, et al. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study. J Am Coll Cardiol 2007;49:539-546.
16. Prospective Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Acute ST-Elevation Myocardial Infarction: PROSIT Trial. Catheter Cardiovasc Interv 2008;72:25-32.
17. Galløe AM, Thuesen L, Kelbæk H, et al. Comparison of Paclitaxel- and Sirolimus-eluting stents in everyday clinical practice. The SORT OUT II Randomized Trial. JAMA 2008;299:409-416.
18. Wessely R, Kastrati A, Mehilli J, et al. Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design. Eur Heart J 2007;22:2720-2725.
19. Lee SW, Park SW, Kim YH, et al. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus. J Am Coll Cardiol 2008;52:727-733.
20. Kim MH, Hong SJ, Cha KS, et al. Effect of paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients. J Interv Cardiol 2008;21:225-231.
21. Mehilli J, Kastrati A, Byrne RA, et al; LEFT-MAIN Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions Study Investigators. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2009;53:1760-1768.
22. Juwana YB, Suryapranata H, Ottervanger JP, et al. Comparison of rapamycin and paclitaxel eluting stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction. Am J Cardiol 2009:104;205-209.
23. de la Torre-Hernández JM, Alfonso F, Hernández F, et al. Drug-eluting stent thrombosis: Results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol 2008;51:986-990.
24. Melfi R, Nusca A, Patti G, Di Sciascio G. The risks and benefits of drug-eluting stents in the setting of STEMI. Curr Cardiol Rep 2008;10:402-406.
25. Kastrati A, Dibra A, Spaulding C, et al. Meta-analysis of randomized trials on drugeluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 2007;28:2706-2713.
26. De Luca G, Stone GW, Suryapranata H, et al. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized trials. Int J Cardiol 2009;133:213-222.
27. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
28. Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005;112:270-278.
29. Parry TJ, Brosius R, Thyagarajan R, et al. Drug-eluting stents: Sirolimus and paclitaxel differentially affect cultured cells and injured arteries. Eur J Pharmacol 2005;524:19-29.
30. Jensen LO, Maeng M, Thayssen P, et al. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial. Eur Heart J 2008;29:2733-2741.
31. Li JJ, Yan HB, Xiang XP, et al. Comparison of changes in early inflammatory markers between sirolimus-and paclitaxel-eluting stent implantation. Cardiovasc Drugs Ther 2009;23:137-143.
32. Stone GW, Midei M, Newman W, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: A randomized trial. JAMA 2008;299:1903-1913.
33. Stone GW, Midei M, Newman W, et al, investigators tSI. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: Two-year clinical follow-up from the SPIRIT III Trial. Circulation 2009;119:680-686.
34. Stone G. SPIRIT IV: A prospective randomized trial of everolimus-eluting vs. paclitaxel-eluting stents available at http://www.tctmd.com.
35. Kedhi E, Joesoef KS, McFadden E, et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): A randomised trial. Lancet 2010;375:201-209.